{"id":"W2949232069","doi":"10.1136/annrheumdis-2019-eular.3403","title":"THU0167 SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM","year":2019,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Rheumatoid arthritis; Discontinuation; Adverse effect; Placebo; Adalimumab; Internal medicine; Methotrexate; Phases of clinical research; Clinical trial; Pharmacology; Gastroenterology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001252873,0.0002470405,0.001274684,0.0001680921,0.00005448979,0.00002917985,0.0006730224,0.0001168909,0.001537194],"category_scores_gemma":[0.003246782,0.0001319732,0.0008785639,0.001805616,0.0005221443,0.0001060888,0.000210993,0.0003285538,0.00006957739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002874024,"about_ca_system_score_gemma":0.003891906,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002041739,"about_ca_topic_score_gemma":0.0001961277,"domain_scores_codex":[0.9959766,0.0006877456,0.001564924,0.0004041846,0.0009149245,0.0004516756],"domain_scores_gemma":[0.9952468,0.002205489,0.000567089,0.001396215,0.0003892614,0.0001951901],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.007912832,0.01119105,0.3657556,0.001067743,0.009762825,0.00003431958,0.001516024,0.0003059016,0.0001349448,0.0003541644,0.01434008,0.5876245],"study_design_scores_gemma":[0.07348173,0.002923449,0.7398046,0.01508907,0.001841887,0.00003333078,0.003591434,0.152004,0.005551965,0.001634519,0.003267388,0.0007766579],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918063,0.003817948,0.00002032859,0.001025715,0.00009018744,0.002150042,0.0005474629,0.00004760883,0.0004944471],"genre_scores_gemma":[0.994973,0.004017651,0.000186244,0.0002086024,0.00002228508,0.0001066058,0.0002579255,0.00002775042,0.0001999247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5868479,"threshold_uncertainty_score":0.9993755,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04611880106264763,"score_gpt":0.3990381520886491,"score_spread":0.3529193510260014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}